Standout Papers

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized doubl... 2009 2026 2014 2020 675
  1. Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial (2009)
    Kathleen Hawker, Paul O’Connor et al. Annals of Neurology

Immediate Impact

24 from Science/Nature 70 standout
Sub-graph 1 of 21

Citing Papers

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
Mechanisms of long COVID and the path toward therapeutics
2024 Standout
14 intermediate papers

Works of Peter Chin being referenced

Immunogenicity with Repeated Dosing of Ocrelizumab in Patients with Multiple Sclerosis (P2.087)
2016
Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial
2009 Standout

Author Peers

Author Last Decade Papers Cites
Peter Chin 807 183 211 370 261 53 1.5k
Jop Mostert 1028 277 201 453 219 71 1.8k
Carla Buttinelli 670 265 200 215 204 55 1.6k
Marta Radaelli 1095 192 217 466 98 57 1.5k
Antonio Carotenuto 1085 226 234 397 206 130 1.9k
Maria Donata Benedetti 940 360 245 723 281 68 1.9k
Davide Maimone 643 242 184 462 218 58 1.7k
Dorothée Chabas 1237 290 300 655 224 34 2.1k
Florian Then Bergh 756 232 138 533 98 59 1.6k
Pasquale Annunziata 471 343 190 405 335 62 1.6k
Lael A. Stone 1059 181 323 344 108 32 1.7k

All Works

Loading papers...

Rankless by CCL
2026